BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25029089)

  • 1. Structural and functional characterization of a cytochrome P450 2B4 F429H mutant with an axial thiolate-histidine hydrogen bond.
    Yang Y; Zhang H; Usharani D; Bu W; Im S; Tarasev M; Rwere F; Pearl NM; Meagher J; Sun C; Stuckey J; Shaik S; Waskell L
    Biochemistry; 2014 Aug; 53(31):5080-91. PubMed ID: 25029089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Proximal Cysteine Hydrogen Bonding Interaction in Cytochrome P450 2B4 Studied by Cryoreduction, Electron Paramagnetic Resonance, and Electron-Nuclear Double Resonance Spectroscopy.
    Davydov R; Im S; Shanmugam M; Gunderson WA; Pearl NM; Hoffman BM; Waskell L
    Biochemistry; 2016 Feb; 55(6):869-83. PubMed ID: 26750753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome b5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4.
    Zhang H; Hamdane D; Im SC; Waskell L
    J Biol Chem; 2008 Feb; 283(9):5217-25. PubMed ID: 18086668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abolition of oxygenase function, retention of NADPH oxidase activity, and emergence of peroxidase activity upon replacement of the axial cysteine-436 ligand by histidine in cytochrome P450 2B4.
    Vatsis KP; Peng HM; Coon MJ
    Arch Biochem Biophys; 2005 Feb; 434(1):128-38. PubMed ID: 15629116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protonation of the Hydroperoxo Intermediate of Cytochrome P450 2B4 Is Slower in the Presence of Cytochrome P450 Reductase Than in the Presence of Cytochrome b5.
    Pearl NM; Wilcoxen J; Im S; Kunz R; Darty J; Britt RD; Ragsdale SW; Waskell L
    Biochemistry; 2016 Nov; 55(47):6558-6567. PubMed ID: 27797496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-site mutation (F429H) converts the enzyme CYP 2B4 into a heme oxygenase: a QM/MM study.
    Usharani D; Zazza C; Lai W; Chourasia M; Waskell L; Shaik S
    J Am Chem Soc; 2012 Mar; 134(9):4053-6. PubMed ID: 22356576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FMN "140s Loop" of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450.
    Rwere F; Im S; Waskell L
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F429 Regulation of Tunnels in Cytochrome P450 2B4: A Top Down Study of Multiple Molecular Dynamics Simulations.
    Mancini G; Zazza C
    PLoS One; 2015; 10(9):e0137075. PubMed ID: 26415031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase.
    Zhang H; Gruenke L; Arscott D; Shen A; Kasper C; Harris DL; Glavanovich M; Johnson R; Waskell L
    Biochemistry; 2003 Oct; 42(40):11594-603. PubMed ID: 14529269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the length and sequence of the linker domain of cytochrome b5 in stimulating cytochrome P450 2B4 catalysis.
    Clarke TA; Im SC; Bidwai A; Waskell L
    J Biol Chem; 2004 Aug; 279(35):36809-18. PubMed ID: 15194706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization and spectroscopic characterization of the dioxygen complex of wild-type cytochrome P4502B4 (CYP2B4) and its distal side E301Q, T302A and proximal side F429H mutants at subzero temperatures.
    Perera R; Sono M; Kinloch R; Zhang H; Tarasev M; Im SC; Waskell L; Dawson JH
    Biochim Biophys Acta; 2011 Jan; 1814(1):69-75. PubMed ID: 20637316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.
    Locuson CW; Wienkers LC; Jones JP; Tracy TS
    Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding.
    Scott EE; White MA; He YA; Johnson EF; Stout CD; Halpert JR
    J Biol Chem; 2004 Jun; 279(26):27294-301. PubMed ID: 15100217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of active-site cysteine-436 by serine converts cytochrome P450 2B4 into an NADPH oxidase with negligible monooxygenase activity.
    Vatsis KP; Peng HM; Coon MJ
    J Inorg Biochem; 2002 Sep; 91(4):542-53. PubMed ID: 12237221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase.
    Bridges A; Gruenke L; Chang YT; Vakser IA; Loew G; Waskell L
    J Biol Chem; 1998 Jul; 273(27):17036-49. PubMed ID: 9642268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5).
    Im SC; Waskell L
    Arch Biochem Biophys; 2011 Mar; 507(1):144-53. PubMed ID: 21055385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resonance Raman studies of cytochrome P450 2B4 in its interactions with substrates and redox partners.
    Mak PJ; Im SC; Zhang H; Waskell LA; Kincaid JR
    Biochemistry; 2008 Mar; 47(12):3950-63. PubMed ID: 18311926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residue 285 in cytochrome P450 2B4 lacking the NH(2)-terminal hydrophobic sequence has a role in the functional association of NADPH-cytochrome P450 reductase.
    Schulze J; Tschöp K; Lehnerer M; Hlavica P
    Biochem Biophys Res Commun; 2000 Apr; 270(3):777-81. PubMed ID: 10772901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P450 active site architecture and reversibility: inactivation of cytochromes P450 2B4 and 2B4 T302A by tert-butyl acetylenes.
    Blobaum AL; Harris DL; Hollenberg PF
    Biochemistry; 2005 Mar; 44(10):3831-44. PubMed ID: 15751959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
    Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
    Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.